Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244
1 - 50 out of 57Page size: 50
Sort by: Type
  1. Membership in research network

  2. American Association for Cancer Research (AACR) (External organisation)

    Andersen, Jesper Bøje (Member)

    2009

    Activity: Membership types › Membership in research network

  3. European Network Study for Cholangiocarcinoma: ENS-CCA (External organisation)

    Andersen, Jesper Bøje (Board member)

    Apr 2015

    Activity: Membership types › Membership in research network

  4. International Liver Cancer Association (ILCA) (External organisation)

    Andersen, Jesper Bøje (Member)

    2010

    Activity: Membership types › Membership in research network

  5. The Cancer Genome Atlas (TCGA), Cholangiocarcinoma Analysis Working Group (External organisation)

    Andersen, Jesper Bøje (Member)

    2014 → …

    Activity: Membership types › Membership in research network

  6. The Cancer Genome Atlas: Tumor Molecular Pathology (TMP) Analysis Working Group (External organisation)

    Andersen, Jesper Bøje (Member)

    2017

    Activity: Membership types › Membership in research network

  7. The Cancer Genome Atlas: pan-TGFb Network (External organisation)

    Andersen, Jesper Bøje (Member)

    2017

    Activity: Membership types › Membership in research network

  8. The Italian chapter of the International Cholangiocarcinoma Network (External organisation)

    Andersen, Jesper Bøje (Member)

    2013

    Activity: Membership types › Membership in research network

  9. Membership in committee, council, board

  10. Eu-Life: Translational Working Group (External organisation)

    Andersen, Jesper Bøje (Member)

    2014

    Activity: Membership types › Membership in committee, council, board

  11. Lecture and oral contribution

  12. 4th Symposium on Translational Genomics with a Special Focus on Liver

    Andersen, Jesper Bøje (Invited speaker)

    Mar 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  13. AASLD: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma.: Experimental Hepatocarcinogenesis

    Andersen, Jesper Bøje (Speaker)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  14. BRIC-Lund University Retreat

    Andersen, Jesper Bøje (Speaker)

    2015

    Activity: Talk or presentation types › Lecture and oral contribution

  15. Bench to Bedside: New Directions for Therapy in Primary Liver Cancer: Cancer Biology Symposium

    Andersen, Jesper Bøje (Invited speaker)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  16. Bench to Bedside: Translational genomics identifies promising targeted therapy for cholangiocarcinoma: Humanitas Fondazione per la Ricerca Seminars

    Andersen, Jesper Bøje (Lecturer)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  17. BioPeople: Future of Oncology Biomarkers Seminar & Biomed

    Andersen, Jesper Bøje (Panel member)

    May 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  18. Center for Excellence and Integrative Cancer Biology and Genomics, NIH

    Andersen, Jesper Bøje (Invited speaker)

    17 Mar 2016 → 18 Mar 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  19. Chair: Liver cancer session

    Andersen, Jesper Bøje (Panel member)

    Sep 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  20. Cholangiocarcinoma Foundation Congress: Translational genomics: Application of murine models for understanding tumor heterogeneity

    Andersen, Jesper Bøje (Invited speaker)

    3 Feb 2016 → 6 Feb 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  21. EASL: Modulation of Demethylation and Antitumor Potential of Zebularine in Liver Cancer

    Andersen, Jesper Bøje (Speaker)

    2009

    Activity: Talk or presentation types › Lecture and oral contribution

  22. Emerging Targets in the treatment of Cholangiocarcinoma: Liver cancer seminar

    Andersen, Jesper Bøje (Lecturer)

    20 Nov 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  23. European Network Study for Cholangiocarcinoma: 1st International monothematic congress in cholangiocarcinoma: Molecular pathogenesis of intrahepatic cholangiocarcinoma

    Andersen, Jesper Bøje (Invited speaker)

    4 May 2016 → 6 May 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  24. Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

    Andersen, Jesper Bøje (Speaker)

    2011

    Activity: Talk or presentation types › Lecture and oral contribution

  25. Georgetown University, Lombardi Comprehensive Cancer Center: Emerging Genomics-based Targets in the treatment of Cholangiocarcinoma: Ruesch symposium on HCC

    Andersen, Jesper Bøje (Invited speaker)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  26. Hallas-Møller Fellowship

    Andersen, Jesper Bøje (Other)

    Apr 2015

    Activity: Talk or presentation types › Lecture and oral contribution

  27. Hepatobiliary cancers: Translational Genomics Directs Therapeutic Options

    Andersen, Jesper Bøje (Invited speaker)

    Aug 2015

    Activity: Talk or presentation types › Lecture and oral contribution

  28. Highlight from Hepatology 2015: From Chronic Hepatitis to HCC: Molecular pathogenesis and current therapy in intrahepatic cholangiocarcinoma

    Andersen, Jesper Bøje (Invited speaker)

    Oct 2015

    Activity: Talk or presentation types › Lecture and oral contribution

  29. ILCA workshop: Signalling pathways and molecular therapies in liver cancer: Rationale for Targeted Therapies in Intrahepatic Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  30. ILCA: Application of Translational Genomics for Targeted Therapy in Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  31. ILCA: Decoding Tumor Heterogeneity Informs Targeted Therapies in Intrahepatic Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    4 Sep 2014

    Activity: Talk or presentation types › Lecture and oral contribution

  32. ILCA: Genomic and Epigenetic-Based Prediction of Response to Zebularine Therapy in Human Liver Cancer

    Andersen, Jesper Bøje (Speaker)

    2009

    Activity: Talk or presentation types › Lecture and oral contribution

  33. ILCA: Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

    Andersen, Jesper Bøje (Speaker)

    2011

    Activity: Talk or presentation types › Lecture and oral contribution

  34. ILCA: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  35. ILCA: Molecular classification and key drivers of intrahepatic CCA

    Andersen, Jesper Bøje (Invited speaker)

    Sep 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  36. ILCA: Transcriptomic classification and survival prediction of human cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2010

    Activity: Talk or presentation types › Lecture and oral contribution

  37. ISICR: The Ribosomal Machinery is a Primary Target of RNase-L Regulation and may mediate its Roles in Senescence and Longevity

    Andersen, Jesper Bøje (Speaker)

    2007

    Activity: Talk or presentation types › Lecture and oral contribution

  38. Korean liver week

    Andersen, Jesper Bøje (Invited speaker)

    Jun 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  39. Liver Cancer Seminar Series

    Andersen, Jesper Bøje (Invited speaker)

    1 Dec 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  40. Molecular Classification of Cholangiocarcinoma and Therapeutic Implications

    Andersen, Jesper Bøje (Invited speaker)

    9 May 2014

    Activity: Talk or presentation types › Lecture and oral contribution

  41. Molecular pathogenesis of cholangiocarcinoma

    Andersen, Jesper Bøje (Lecturer)

    Oct 2015

    Activity: Talk or presentation types › Lecture and oral contribution

  42. Mutagen-Brazil: Translational Research

    Andersen, Jesper Bøje (Invited speaker)

    28 Jan 2016 → 30 Jan 2016

    Activity: Talk or presentation types › Lecture and oral contribution

  43. NAFLD

    Andersen, Jesper Bøje (Invited speaker)

    24 Nov 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  44. Novel Therapeutic Approaches for Treatment of Primary Liver Cancer: Epigenomic-driven therapy

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  45. Riccardo Cortese memorial lecture

    Andersen, Jesper Bøje (Invited speaker)

    Jul 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  46. Satorius Research Xchange Forum: Insights, Translation and Solutions

    Andersen, Jesper Bøje (Invited speaker)

    21 Feb 2017 → 23 Feb 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  47. The Hepatobiliary Cancers Foundation (CanLiv): Genomic Basis for Targeted Therapies in Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  48. University of Mainz, Medicine 1: Liver lunch

    Andersen, Jesper Bøje (Invited speaker)

    28 Mar 2017

    Activity: Talk or presentation types › Lecture and oral contribution

  49. Organisation of and participation in conference

  50. EU-Life: Epigenetics and Disease

    Andersen, Jesper Bøje (Organizer)

    11 May 2015 → 13 May 2015

    Activity: Participating in an event - types › Organisation of and participation in conference

  51. Peer review of manuscripts

  52. Breast Cancer Research; Biochemical Pharmacology (Journal)

    Andersen, Jesper Bøje (Review editor)

    2008

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  53. British Journal of Cancer; Journal of Cancer Therapeutics & Research, BMC Cancer; Cancer Research; Clinical Cancer Research; PLoS ONE (Journal)

    Andersen, Jesper Bøje (Review editor)

    2012

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  54. Gastroenterology; Liver Transplantation; Clinical Gastroenterology & Hepatology (Journal)

    Andersen, Jesper Bøje (Review editor)

    2011

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  55. Gut, Molecular Carcinogenesis, Oncogene (Journal)

    Andersen, Jesper Bøje (Review editor)

    2013

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

Previous 1 2 Next

ID: 93714085